PLASMA DISPOSITION OF CEFOPERAZONE AFTER SINGLE INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATIONS IN CAMELS (CAMELUS DROMEDARIUS)
dc.contributor.author | Aboubakr, Mohamed | |
dc.contributor.author | Soliman, Ahmed | |
dc.contributor.author | Uney, Kamil | |
dc.contributor.author | Elmas, Muammer | |
dc.date.accessioned | 2020-03-26T19:55:11Z | |
dc.date.available | 2020-03-26T19:55:11Z | |
dc.date.issued | 2018 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | The plasma disposition of cefoperazone was investigated after intravenous (IV) and intramuscular (IM) administrations of 20 mg/kg as a single dose in six camels (Camelus dromedarius) in a crossover design. Blood plasma samples were analysed by high-performance liquid chromatography (HPLC). After IV administration, elimination half-life (t(1/2 beta)), volume of distribution at steady state (V-dss), total body clearance (Cl-tot) and mean residence time (MRT) of cefoperazone were 1.95 h, 0.38 L/kg, 0.17 L/h/kg and 2.16 h, respectively. After IM administration of cefoperazone, peak plasma concentration (C-max) was 21.95 mu g/mL and it was obtained at (t(max)) 1.23 h. Absorption half-life (t(1/2ab)), elimination half-life and mean absorption time were 0.45 h, 2.84 h and 2.07 h, respectively. The bioavailability of cefoperazone was 89.42%. The lack of local reaction or any other adverse effects and the very good bioavailability following IM administration indicate that cefoperazone might be a promising alternative treatment for a variety of infectious diseases in camels. | en_US |
dc.identifier.doi | 10.1556/004.2018.039 | en_US |
dc.identifier.endpage | 450 | en_US |
dc.identifier.issn | 0236-6290 | en_US |
dc.identifier.issn | 1588-2705 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 30264621 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 444 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1556/004.2018.039 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/36867 | |
dc.identifier.volume | 66 | en_US |
dc.identifier.wos | WOS:000445898600009 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | AKADEMIAI KIADO ZRT | en_US |
dc.relation.ispartof | ACTA VETERINARIA HUNGARICA | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Cefoperazone | en_US |
dc.subject | concentrations | en_US |
dc.subject | bioavailability | en_US |
dc.subject | camels | en_US |
dc.title | PLASMA DISPOSITION OF CEFOPERAZONE AFTER SINGLE INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATIONS IN CAMELS (CAMELUS DROMEDARIUS) | en_US |
dc.type | Article | en_US |